Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 62 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMA POSITIVE from Sint-Lambrechts-Woluwe, company number BE0551980676, closed financial year 2025 with a result of € 296,232 after tax. For that financial year PHARMA POSITIVE recorded a gross margin of € 852,357 and equity of € 576,974. Compared with financial year 2024, the result moved from € 318,322 to € 296,232. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 576,974
▲ 92% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 296,232
▼ 7% vs 2024
Profit after tax over the fiscal year.
€ 457,188
▲ 39% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 20,000 paid out
7 % of the profit went to the shareholders, mostly to CC Group (100 % of the shares). That is where the money ends up.
People and assets in 2025
4.4
▼ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 265,280
▼ 4% vs 2024
€ 60,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,664
▲ 298% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 649,845
▼ 30% vs 2024
€ 203,127 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 117,683
▼ 10% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 38,844
▼ 4% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 726,912 | € 771,199 | € 863,230 | € 852,357 | ▼ 1% |
| Profit after taxes | € 208,284 | € 262,909 | € 318,322 | € 296,232 | ▼ 7% |
| Equity | € 1,022,511 | € 1,215,420 | € 300,742 | € 576,974 | ▲ 92% |
| Total debts | € 1,547,789 | € 1,343,639 | € 1,808,239 | € 1,514,152 | ▼ 16% |
| Cash | € 489,989 | € 359,401 | € 329,215 | € 457,188 | ▲ 39% |
| Land & buildings | € 119,538 | € 112,370 | € 108,300 | € 104,806 | ▼ 3% |
| Retained profit | € 922,511 | € 1,115,420 | € 200,742 | € 476,974 | ▲ 138% |
| Dividend | € 0 | € 70,000 | € 1,233,000 | € 20,000 | ▼ 98% |
| Bank debt | € 1,320,064 | € 1,116,779 | € 924,154 | € 649,845 | ▼ 30% |
| Balance sheet total | € 2,570,300 | € 2,559,059 | € 2,108,981 | € 2,091,126 | ▼ 1% |
| Employees (FTE) | 3.5 | 3.5 | 4.5 | 4.4 | ▼ 0.1 |
Key figures of PHARMA POSITIVE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMA POSITIVE?
What happened at PHARMA POSITIVE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 296,232 (▼ 7% vs 2024). Source: NBB ↗
- CC GROUP SRL became a director. NBB
- New establishment in Sint-Lambrechts-Woluwe. KBO
- Start of the company according to the CBE. KBO
In short
From € 208,284 profit in 2022 to € 296,232 profit in 2025.
Paid € 438,905 in corporate taxes since 2022.
Best year ever: 2024, with € 318,322 profit.
On average € 193,700 of value added per employee in 2025.
A new publication or filing at PHARMA POSITIVE? We notify you, reason included.
Follow PHARMA POSITIVEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of CC Group comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMA POSITIVEBehind PHARMA POSITIVE is CC GROUP SRL. The shares are held by CC Group (100%).
Directors
According to the 2025 annual accounts
Administrator-manager · represented by CAROLINE PEUCHOT
since 2019
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Théodore De Cuyperstraat 165
1200 Sint-Lambrechts-Woluwe
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0551.980.676
- VAT number
- BE 0551.980.676
- Registered office
- Théodore De Cuyperstraat 165, 1200 Sint-Lambrechts-Woluwe
- Names & denominations
- PHARMA POSITIVE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 May 2014
- Peppol
- Active · Active since 16 Jun 2025
- Contact
- [email protected]
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Adviesbureaus op het gebied van public relations en communicatie
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels